Condition: Primary Aldosteronism · Secondary Hypertension · Aldosterone-Producing Adenoma · Sponsor: Seoul National University Hospital
This study is a randomized controlled trial to assess the clinical utility of gallium-68 pentixafor PET/CT in the management of primary aldosteronism (PA). We aim to evaluate whether the addition of 68Ga-pentixafor PET/CT to standard adrenal venous sampling (AVS) improves surgical outcomes in patients with unilateral PA.
This description comes directly from the study's public registry record.
Seungho Lee, M.D · 82-10-8629-9209 · ganymedes10@gmail.com
Always discuss trial participation with your own doctor first.
| Samsung Medical Center | Seoul, Gangnam-gu, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, Jongno-gu, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07027254